Live news related to IBA stock (BE0003766806): press releases, earnings publications, share price moves, analyst notes and corporate events. This page is auto-updated whenever new financial information is available.
IBA has announced that its contract signed in April with the Portuguese Institute of Oncology of Porto (IPO-Porto) has come into effect following appr…
IBA signed a contract on Thursday with the Fundação Severino Sombra (FUSVE), a Brazilian non-profit institution, to set up a Proteus One system in Rio…
IBA announces a reorganization of its executive responsibilities. Olivier Legrain, who has led the company since 2012, becomes Vice-Chairman of the Bo…
On Wednesday, IBA signed a sponsored research agreement with the University of Texas MD Anderson Cancer Center, aiming to generate robust clinical and…
IBA announced on Monday the signing of a contract with Duke University Health System for the installation of two Proteus One proton therapy solutions …
IBA (Ion Beam Applications) announced on Monday the launch of Cyclone iKure, a cyclotron dedicated to the clinical-scale production of Astatine-211. T…
The stock of Belgian proton therapy specialist IBA marked a significant increase of 5.11% by midday on Monday, December 29, reaching 12.76 euros from …
IBA shares saw a significant rise this Thursday, November 20, at mid-session, driven by the publication of its third-quarter results and the announcem…
